跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Desmopressin Acetate Injection
Approved
化学药品
Desmopressin Acetate Injection
Ferring AG
🇨🇳 National Medical Products Administration
Approval Date
Mar 17, 2022
Approval ID
8F2ZxtM7bqu
Company
Ferring AG
Type
化学药品
Approval Details
Approval Id
8F2ZxtM7bqu
Approval Number
国药准字HJ20170093
Generic Name
醋酸去氨加压素注射液
Generic Name En
Desmopressin Acetate Injection
Trade Name
弥柠
Drug Type
化学药品
Dosage Form
注射剂
Strength
1ml:4μg(按去氨加压素计为3.56μg)
Reg Date
2022-03-17
Expired Date
2027-03-16
Company Name
Ferring AG
Production Company Name
Rechon Life Science AB
Company Detail Path
/organization/ferring-ag
Production Company Detail Path
/organization/rechon-life-science-ab
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 17, 2022
Approval ID
8F2ZxtM7bqu
Type
化学药品
Back to NMPA Approvals
弥柠 - NMPA Drug Approval Details